Influenza virus: Being the most beneficial mutation is no guarantee of long-term genetic success, research finds

January 3, 2013
Positive selection over time of a single mutation affects the entire gene. Credit: Genome Research Limited

(Medical Xpress)—Wellcome Trust Sanger Institute scientists have used computer modelling to understand why some mutations in a virus gene rise to dominance and become 'fixed' in the genome of the virus, while others die out. Their findings were based upon real-world observations of the evolution of a human flu virus, using genome sequences collected over many years by researchers worldwide.

The team studied mutations in the haemagglutinin gene of the human A/H3N2, which latches the virus on to during an infection. Using a computer model, the team identified three key factors that determine the long-term survival of a mutation. The three factors are: the benefit the mutation confers to the virus; the background of other mutations that were present in the gene when the mutation appeared; and the effect of subsequent competition from different versions of the same gene in sibling viruses. To test the influence of each of these factors, they applied their model to the changes seen in the haemagglutinin gene between 1996 and the present day.

"We are keen to understand how within the works over time and around the world," says Dr Chris Illingworth, first author of the study, from the Sanger Institute. "In some ways, the flu virus is very simple. When a person catches flu, their cells become incubators for the virus. Within each cell, the virus produces copies of itself. However, the evolution of the virus is not so simple. The copying process is highly error-prone, so that the new viruses often contain mutations. New mutations can either help or hinder the virus from spreading. But having the best mutation doesn't guarantee .

"Previous approaches to studying viral evolution have often thought about mutations one at a time, in isolation from each other. But at any one time, a large number of mutations exist. Viruses with different sets of mutations compete against each other, and the combined effect of all of the mutations must be taken into account."

The computer model developed by the researchers considered the benefit, or disadvantage, of each mutation, but also looked at whether pairs of mutations appeared together (in the same virus), or apart (in different viruses). In the model, beneficial mutations in the same virus help each other out, while beneficial mutations in different viruses compete. In the haemagglutinin gene of human influenza A/H3N2 an average of seven new mutations fix in the virus population each year. By analysing which gene variations became dominant and which did not since 1996, the team arrived at their result.

"You might expect that the most beneficial single mutation in a gene would always be the most successful in fixing into the virus' genome, but this is not what we found," explains Dr Ville Mustonen, senior author of the paper, from the Sanger Institute. "Our analysis of genome sequences of the reveals that two other factors are important for a mutation's success: the sequence of the version of the gene upon which a mutation appeared (how beneficial or not other mutations within the gene are) and the competition from other forms of the gene with different mutations."

The computer model developed by the team built on methods they had employed for studying evolution in a population using genetic sequence data collected across multiple points in time. The approach accounted for the fact that positive selection - where a beneficial mutation enables a virus to thrive - affects the other mutations occurring across the virus gene, either for their benefit, or for their loss. For example, an unhelpful mutation could succeed if it was coupled to a very beneficial mutation further along the gene - hitchhiking to success. However, a weakly beneficial mutation, if it was opposed by another, stronger mutation, could be caused to die out.

"For the first time, we are able to study the adaptive dynamics of a viral population at the level of individual mutations," adds Chris Illingworth. "We can do this because our method looks at selection across the entire gene, estimating both the relative benefit of the genomic background upon which the mutation appeared, and the combined effect of interference from other mutations on the genome over its lifetime. Statistically, we found that mutations were more likely to become fixed in the flu population if they were beneficial for the virus, had been fortunate to appear on more beneficial backgrounds, and had encountered less opposition from other ."

The new could potentially aid in predicting how the flu virus might change in the future. However, further research is needed to discover the true potential of this approach. "We need to be cautious before making bold claims," says Ville Mustonen. "Our mathematical model, like all such approaches, is based on a number of assumptions. The next question to answer is whether or not the model matches reality closely enough to make useful predictions."

Explore further: Avian flu viruses which are transmissible between humans could evolve in nature

More information: Illingworth, CJR and Mustonen, V. Components of Selection in the Evolution of the Influenza Virus: Linkage Effects Beat Inherent Selection. PLoS Pathogens, 2012. … journal.ppat.1003091

Related Stories

Avian flu viruses which are transmissible between humans could evolve in nature

June 21, 2012
It might be possible for human-to-human airborne transmissible avian H5N1 influenza viruses to evolve in nature, new research has found. The findings, from research led by Professor Derek Smith and Dr Colin Russell at the ...

Tracking a moving target

July 15, 2011
The influenza pandemic that began in Mexico in April 2009 rapidly spread throughout the world and arrived in Japan one month later. Now, a research team led by Toshihisa Ishikawa at the RIKEN Omics Science Center in Yokohama ...

Recommended for you

Google searches can be used to track dengue in underdeveloped countries

July 20, 2017
An analytical tool that combines Google search data with government-provided clinical data can quickly and accurately track dengue fever in less-developed countries, according to new research published in PLOS Computational ...

MRSA emerged years before methicillin was even discovered

July 19, 2017
Methicillin resistant Staphylococcus aureus (MRSA) emerged long before the introduction of the antibiotic methicillin into clinical practice, according to a study published in the open access journal Genome Biology. It was ...

New test distinguishes Zika from similar viral infections

July 18, 2017
A new test is the best-to-date in differentiating Zika virus infections from infections caused by similar viruses. The antibody-based assay, developed by researchers at UC Berkeley and Humabs BioMed, a private biotechnology ...

'Superbugs' study reveals complex picture of E. coli bloodstream infections

July 18, 2017
The first large-scale genetic study of Escherichia coli (E. coli) cultured from patients with bloodstream infections in England showed that drug resistant 'superbugs' are not always out-competing other strains. Research by ...

Ebola virus can persist in monkeys that survived disease, even after symptoms disappear

July 17, 2017
Ebola virus infection can be detected in rhesus monkeys that survive the disease and no longer show symptoms, according to research published by Army scientists in today's online edition of the journal Nature Microbiology. ...

Mountain gorillas have herpes virus similar to that found in humans

July 13, 2017
Scientists from the University of California, Davis, have detected a herpes virus in wild mountain gorillas that is very similar to the Epstein-Barr virus in humans, according to a study published today in the journal Scientific ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.